Natural Product Scaffolds as Leads to Drugs
Authors:
- 13 November 2009
- journal article
- review article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 1 (8) , 1415-1427
Abstract
Numerous 'scaffolds' that have been identified in natural product structures have led to very significant numbers of approved drugs and drug candidates for a multiplicity of diseases over the years. In this mini-review, we discuss the base scaffolds (chemical skeletons) that we feel have produced very significant numbers of agents as drugs or drug leads and, in a number of cases, compounds that can be used as chemical synthons or that present activities in biological areas that were not obvious from their earlier history.Keywords
This publication has 82 references indexed in Scilit:
- An Environmental DNA‐Derived Type II Polyketide Biosynthetic Pathway Encodes the Biosynthesis of the Pentacyclic Polyketide ErdacinAngewandte Chemie International Edition, 2009
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignanciesBritish Journal of Haematology, 2009
- Decoding and engineering tetracycline biosynthesisMetabolic Engineering, 2009
- A Robust Platform for the Synthesis of New Tetracycline AntibioticsJournal of the American Chemical Society, 2008
- Catalytic site-selective synthesis and evaluation of a series of erythromycin analogsBioorganic & Medicinal Chemistry Letters, 2008
- Therapeutic effect against human xenograft tumors in nude mice by the third generation microtubule stabilizing epothilonesProceedings of the National Academy of Sciences, 2008
- Protein−Protein Interaction Detection in Vitro and in Cells by Proximity BiotinylationJournal of the American Chemical Society, 2008
- Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activitiesProceedings of the National Academy of Sciences, 2008
- EDP-420, a Bicyclolide (Bridged Bicyclic Macrolide), Is Active against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 2007
- POTENTIAL ANTICANCER AGENTS.1 XL. SYNTHESIS OF THE β-ANOMER OF 9-(D-ARABINOFURANOSYL)-ADENINEJournal of the American Chemical Society, 1960